Skip to main content
OGEN logo

OGEN · Oragenics Inc

$0.54 0.00 (-0.20%) At close · Jul 21
Market Cap
$2.44M
Shares
4.51M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
79/100
Short interest 17.2% of shares — P97 Days to cover 16.8 — P97 Price vs VWAP -11.0% — P27 Short-volume trend +9.6% — P82 Short interest change +3.0% — P55 Worst FTD 0.22% of shares — P83

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 775,021 752,810 +22,211 16.84
2026-06-15 752,810 708,926 +43,884 13.03
2026-05-29 708,926 656,580 +52,346 16.72
2026-05-15 656,580 683,948 -27,368 11.78
2026-04-30 683,948 703,470 -19,522 11.06
2026-04-15 703,470 720,353 -16,883 12.20
2026-03-31 720,353 792,779 -72,426 5.52
2026-03-13 792,779 570,220 +222,559 1.79
2026-02-27 570,220 458,764 +111,456 1.00
2026-02-13 458,764 524,157 -65,393 5.70
2026-01-30 524,157 57,838 +466,319 1.00
2026-01-15 57,838 108,196 -50,358 1.68
2025-12-31 108,196 139,273 -31,077 1.53
2025-12-15 139,273 34,508 +104,765 1.22
2025-11-28 34,508 57,082 -22,574 1.00
2025-11-14 57,082 35,642 +21,440 1.58
2025-10-31 35,642 92,847 -57,205 1.00
2025-10-15 92,847 86,968 +5,879 1.00
2025-09-30 86,968 117,393 -30,425 1.00
2025-09-15 117,393 33,254 +84,139 1.00
2025-08-29 33,254 18,730 +14,524 1.00
2025-08-15 18,730 48,897 -30,167 1.00
2025-07-31 48,897 68,033 -19,136 1.00
Showing 1–23 of 23 settlements
Key facts CIK 1174940 CUSIP 684023609 13F (30d) 1 filings 1 filers Visit website Investor relations